17-7673523-A-G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_000546.6(TP53):​c.993+12T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0134 in 1,613,726 control chromosomes in the GnomAD database, including 169 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.016 ( 18 hom., cov: 31)
Exomes 𝑓: 0.013 ( 151 hom. )

Consequence

TP53
NM_000546.6 intron

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:30

Conservation

PhyloP100: -0.437

Publications

22 publications found
Variant links:
Genes affected
TP53 (HGNC:11998): (tumor protein p53) This gene encodes a tumor suppressor protein containing transcriptional activation, DNA binding, and oligomerization domains. The encoded protein responds to diverse cellular stresses to regulate expression of target genes, thereby inducing cell cycle arrest, apoptosis, senescence, DNA repair, or changes in metabolism. Mutations in this gene are associated with a variety of human cancers, including hereditary cancers such as Li-Fraumeni syndrome. Alternative splicing of this gene and the use of alternate promoters result in multiple transcript variants and isoforms. Additional isoforms have also been shown to result from the use of alternate translation initiation codons from identical transcript variants (PMIDs: 12032546, 20937277). [provided by RefSeq, Dec 2016]
TP53 Gene-Disease associations (from GenCC):
  • breast cancer
    Inheritance: AD Classification: DEFINITIVE Submitted by: Ambry Genetics
  • Li-Fraumeni syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, G2P, Labcorp Genetics (formerly Invitae), Orphanet
  • Li-Fraumeni syndrome 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Genomics England PanelApp
  • adrenocortical carcinoma, hereditary
    Inheritance: AD Classification: STRONG Submitted by: Ambry Genetics
  • sarcoma
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
  • bone marrow failure syndrome 5
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
  • colorectal cancer
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
  • choroid plexus carcinoma
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BP6
Variant 17-7673523-A-G is Benign according to our data. Variant chr17-7673523-A-G is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 93325.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.0156 (2381/152248) while in subpopulation AFR AF = 0.0279 (1158/41538). AF 95% confidence interval is 0.0265. There are 18 homozygotes in GnomAd4. There are 1076 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position passed quality control check.
BS2
High AC in GnomAd4 at 2381 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000546.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TP53
NM_000546.6
MANE Select
c.993+12T>C
intron
N/ANP_000537.3
TP53
NM_001126112.3
c.993+12T>C
intron
N/ANP_001119584.1K7PPA8
TP53
NM_001407262.1
c.993+12T>C
intron
N/ANP_001394191.1K7PPA8

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TP53
ENST00000269305.9
TSL:1 MANE Select
c.993+12T>C
intron
N/AENSP00000269305.4P04637-1
TP53
ENST00000445888.6
TSL:1
c.993+12T>C
intron
N/AENSP00000391478.2P04637-1
TP53
ENST00000610292.4
TSL:1
c.876+12T>C
intron
N/AENSP00000478219.1P04637-4

Frequencies

GnomAD3 genomes
AF:
0.0156
AC:
2376
AN:
152130
Hom.:
16
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0278
Gnomad AMI
AF:
0.0230
Gnomad AMR
AF:
0.00786
Gnomad ASJ
AF:
0.00836
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.00828
Gnomad FIN
AF:
0.00245
Gnomad MID
AF:
0.0158
Gnomad NFE
AF:
0.0139
Gnomad OTH
AF:
0.0172
GnomAD2 exomes
AF:
0.0111
AC:
2797
AN:
251290
AF XY:
0.0115
show subpopulations
Gnomad AFR exome
AF:
0.0275
Gnomad AMR exome
AF:
0.00688
Gnomad ASJ exome
AF:
0.00605
Gnomad EAS exome
AF:
0.0000544
Gnomad FIN exome
AF:
0.00314
Gnomad NFE exome
AF:
0.0141
Gnomad OTH exome
AF:
0.0112
GnomAD4 exome
AF:
0.0132
AC:
19279
AN:
1461478
Hom.:
151
Cov.:
33
AF XY:
0.0130
AC XY:
9432
AN XY:
727060
show subpopulations
African (AFR)
AF:
0.0279
AC:
934
AN:
33478
American (AMR)
AF:
0.00800
AC:
358
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00650
AC:
170
AN:
26136
East Asian (EAS)
AF:
0.0000504
AC:
2
AN:
39700
South Asian (SAS)
AF:
0.0104
AC:
899
AN:
86252
European-Finnish (FIN)
AF:
0.00371
AC:
198
AN:
53410
Middle Eastern (MID)
AF:
0.0130
AC:
75
AN:
5768
European-Non Finnish (NFE)
AF:
0.0143
AC:
15857
AN:
1111646
Other (OTH)
AF:
0.0130
AC:
786
AN:
60364
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.469
Heterozygous variant carriers
0
1007
2014
3021
4028
5035
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
606
1212
1818
2424
3030
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0156
AC:
2381
AN:
152248
Hom.:
18
Cov.:
31
AF XY:
0.0145
AC XY:
1076
AN XY:
74450
show subpopulations
African (AFR)
AF:
0.0279
AC:
1158
AN:
41538
American (AMR)
AF:
0.00778
AC:
119
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.00836
AC:
29
AN:
3470
East Asian (EAS)
AF:
0.000194
AC:
1
AN:
5160
South Asian (SAS)
AF:
0.00829
AC:
40
AN:
4826
European-Finnish (FIN)
AF:
0.00245
AC:
26
AN:
10614
Middle Eastern (MID)
AF:
0.0136
AC:
4
AN:
294
European-Non Finnish (NFE)
AF:
0.0139
AC:
947
AN:
68024
Other (OTH)
AF:
0.0170
AC:
36
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
120
240
359
479
599
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
28
56
84
112
140
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0142
Hom.:
49
Bravo
AF:
0.0169
Asia WGS
AF:
0.00722
AC:
25
AN:
3478

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
8
not specified (8)
-
-
6
Hereditary cancer-predisposing syndrome (6)
-
-
6
not provided (6)
-
-
5
Li-Fraumeni syndrome 1 (5)
-
-
2
Hereditary breast ovarian cancer syndrome (2)
-
-
1
Breast and/or ovarian cancer (1)
-
-
1
Li-Fraumeni syndrome (1)
-
-
1
Malignant tumor of breast (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.84
CADD
Benign
2.0
DANN
Benign
0.80
PhyloP100
-0.44
PromoterAI
-0.0085
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1800899; hg19: chr17-7576841; COSMIC: COSV53015717; API